107 related articles for article (PubMed ID: 2421897)
1. Therapeutic approaches including interferon to carcinoma in situ of the bladder.
Lum BL; Torti FM
Cancer Treat Rev; 1985 Dec; 12 Suppl B():45-59. PubMed ID: 2421897
[TBL] [Abstract][Full Text] [Related]
2. The biology and treatment of superficial bladder cancer.
Torti FM; Lum BL
J Clin Oncol; 1984 May; 2(5):505-31. PubMed ID: 6427417
[TBL] [Abstract][Full Text] [Related]
3. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Soloway MS; Jordan AM; Murphy WM
Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
[TBL] [Abstract][Full Text] [Related]
4. Treatment of superficial carcinoma of the bladder.
Paulson DF
Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
[No Abstract] [Full Text] [Related]
5. BCG versus thiotepa in non-CIS, stage Ta, T1 bladder cancer: rationale and design of ECOG trial.
Fisher HA
Prog Clin Biol Res; 1989; 310():275-83. PubMed ID: 2505271
[No Abstract] [Full Text] [Related]
6. Introduction and overview of intravesical therapy for superficial bladder cancer.
Soloway MS
Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
[TBL] [Abstract][Full Text] [Related]
7. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
8. Superficial bladder cancer.
Trybula M; King M
Med Pediatr Oncol; 1985; 13(6):384-9. PubMed ID: 2413339
[No Abstract] [Full Text] [Related]
9. Treatment modalities in superficial bladder cancer.
Irwin R; Zincke H; Droller MJ; Prout GR; Soloway MS
Semin Urol; 1989 Feb; 7(1 Suppl 1):1-12. PubMed ID: 2499916
[No Abstract] [Full Text] [Related]
10. Current concepts in the management of superficial bladder cancer.
Soloway MS
Arch Esp Urol; 1990; 43 Suppl 2():115-21. PubMed ID: 2129003
[No Abstract] [Full Text] [Related]
11. Intravesical chemotherapy: how effective is it?
Heney NM
Urology; 1988 Mar; 31(3 Suppl):17-9. PubMed ID: 3126591
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant intravesical therapy for superficial bladder cancer.
Batts CN
Ann Pharmacother; 1992 Oct; 26(10):1270-6. PubMed ID: 1421654
[TBL] [Abstract][Full Text] [Related]
13. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
Huben RP
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
[TBL] [Abstract][Full Text] [Related]
14. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder.
Takenaka A; Yamada Y; Miyake H; Hara I; Fujisawa M
Int J Urol; 2008 Apr; 15(4):309-13. PubMed ID: 18380817
[TBL] [Abstract][Full Text] [Related]
16. Review of Mayo Clinic experience with carcinoma in situ.
Zincke H; Utz DC; Farrow GM
Urology; 1985 Oct; 26(4 Suppl):39-46. PubMed ID: 3931327
[TBL] [Abstract][Full Text] [Related]
17. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
18. [Intravesical Bacillus Calmette Guerin treatment of bladder tumors and carcinoma in situ].
Ovesen H
Ugeskr Laeger; 1994 Jan; 156(5):628-31, 634. PubMed ID: 8184493
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
Rintala E; Jauhiainen K; Alfthan O
Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
[No Abstract] [Full Text] [Related]
20. The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder.
Kim JC; Steinberg GD
J Urol; 2001 Mar; 165(3):745-56. PubMed ID: 11176460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
